Mallinckrodt Hospital Products Inc. recalls Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Pro
Recalled February 28, 2024 · FDA recall D-0341-2024 · Mallinckrodt Hospital Products
Hazard
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified. · FDA Class II
Units
421 vials involved in this recall (2,448 vials distributed)
Sold at
USA nationwide
Description
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
Product
Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01
Manufacturer(s)
Mallinckrodt Hospital Products Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →